日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Montelukast alleviates neuroinflammation and improves motor functions in the line 61 model of Parkinson's disease: An exploratory study.

孟鲁司特可减轻帕金森病 61 系模型中的神经炎症并改善运动功能:一项探索性研究

Strempfl Katharina, Zattoni Marco, Mrowetz Heike, Unger Michael S, Schörghofer Nikolaos, Altendorfer Barbara, Neddens Jörg, Flunkert Stefanie, Hutter-Paier Birgit, He Yachao, Wallin Johan, Poupardin Rodolphe W, Pietrantonio Frank, Paiement Nadine, Zerbe Horst, Felder Thomas, Svenningsson Per, Aigner Ludwig

The leukotriene receptor antagonist montelukast as a potential therapeutic adjuvant in multiple sclerosis - a review

白三烯受体拮抗剂孟鲁司特作为多发性硬化症潜在治疗辅助药物——综述

Pietrantonio, Frank; Serreqi, Alex; Zerbe, Horst; Svenningsson, Per; Aigner, Ludwig

The Leukotriene Receptor Antagonist Montelukast as a Potential COVID-19 Therapeutic

白三烯受体拮抗剂孟鲁司特作为潜在的COVID-19治疗药物

Aigner, Ludwig; Pietrantonio, Frank; Bessa de Sousa, Diana Marisa; Michael, Johanna; Schuster, Daniela; Reitsamer, Herbert Anton; Zerbe, Horst; Studnicka, Michael